Immediate Impact
8 standout
Citing Papers
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
Targeting the progression of chronic kidney disease
2020 Standout
Works of Craig A. MacKinnon being referenced
Phosphaturic mesenchymal tumor without osteomalacia: additional confirmation of the “nonphosphaturic” variant, with emphasis on the roles of FGF23 chromogenic in situ hybridization and FN1-FGFR1 fluorescence in situ hybridization
2018
Orbital immunoglobulin IgG4-related inflammatory fibrosclerosing lesion treated with pentoxifylline and α-tocopherol: case report
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Craig A. MacKinnon | 158 | 40 | 32 | 49 | 44 | 20 | 280 | |
| P.J. Mahaffey | 176 | 14 | 20 | 115 | 11 | 22 | 286 | |
| Arash Jian-Amadi | 136 | 89 | 46 | 62 | 20 | 26 | 265 | |
| Brian P. Maloney | 229 | 26 | 14 | 77 | 12 | 19 | 299 | |
| Konrad Knusel | 61 | 26 | 49 | 53 | 17 | 23 | 302 | |
| Jennings R. Boyette | 187 | 107 | 16 | 19 | 26 | 13 | 278 | |
| Márcio Bruno Figueiredo Amaral | 153 | 31 | 20 | 24 | 61 | 37 | 316 | |
| John G. Rose | 155 | 59 | 42 | 64 | 66 | 22 | 332 | |
| Gabriela M. Espinoza | 55 | 59 | 78 | 43 | 52 | 24 | 309 | |
| Janek S. Januszkiewicz | 215 | 37 | 19 | 70 | 44 | 14 | 292 | |
| Lih Ma | 77 | 50 | 27 | 94 | 7 | 21 | 279 |
All Works
Login with ORCID to disown or claim papers
Loading papers...